Financials

Discussions Technicals Seasonals

950220 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

NeoImmuneTech, Inc. is a clinical-stage biopharmaceutical company. which engages in the development of T cell-centered novel immunotherapeutics. The firm develops its product NT-I7 for the treatment of lymphopenia. The company was founded by Se Hwan Yang in January 2014 and is headquartered in Rockville, MD.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

950220 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company